Interview with David Hite, CEO, Alandra Medical México
Before we get into the company’s activities and market, could you give us a brief rundown of your past working experience prior to Alandra Medical? My experience outside of the…
Address: Av San Barnabé 123 col. San Jeronimo lidice CP 10200 México DF,Mexico
Tel: +52 55 5377 3198
Web: http://www.alandramedical.com/
ALANDRA Medical is at the forefront of the offshore medical device innovation ecosystem. We are a medical device company that specializes in Capital Efficiency. At ALANDRA Medical we are dedicated to the research, design and development, and clinical trials of new medical devices. We are an interdisciplinary group of engineers, designers, scientists and medical doctors, providing a compelling suite of core services in the development, testing and clinical trials of new medical devices and medical equipment. Our team has contributed to medical device and medical equipment development in diabetes, cardiology, neurology, minimally-invasive surgery, anesthesiology, critical care, electromagnetic therapy and audiology.
ALANDRA MEDICAL has two core divisions to manage the design, development and research processes for medical devices and medical equipment: Design & Development and CRO & Clinical Validation
Before we get into the company’s activities and market, could you give us a brief rundown of your past working experience prior to Alandra Medical? My experience outside of the…
It’s been one year since you were appointed as Federal Commissioner of COFEPRIS in March 2011. What have been the biggest challenges you’ve faced within this time? The biggest challenge…
Can you tell us a little about the history of Medix and about the company itself? Medix is a 100% Mexican company created in 1956, and our major strength is…
Apotex has increased production, launched 16 new products last March, and grown significantly in the market. What would you say has been the biggest change in the market over the…
The last time we interviewed you was in 2008. Please can you tell our readers a little bit more about Liomont’s growth drivers and changes over these last four years?…
When we saw you in 2008 we had read a little bit about the major milestones in the company, how your grandfather came to Mexico in the 1950s and how…
Please can you tell our readers a little bit more about the history of Stendhal, and its major milestones along the way since its takeover in 1997? Stendhal is a…
Carlos Garcia said in December 2009 that 6-8% of Novartis’ annual revenue comes from Latin America, and that the area is “one of the main growth engines for the company”.…
Big news last year; Takeda bought Nycomed in what has been seen as a game changing acquisition for the pharma world. How have you seen this acquisition affect Nycomed’s Latin…
The Mexican government has been fairly pro-active about promoting good practice such as the new drug registration process that helped eliminate drugs from the Mexican market that didn’t fulfill regulatory…
There have been quite a few regulatory changes in the last few years such as the new drug registration process and the suppression of the local plant rule. COFEPRIS has…
This is your 3rd interview with Focus Reports. What would you say has been the biggest change that has shaped the pharmaceutical industry since we last interviewed you in 2008?…
This is your third interview with Focus Reports. In 2004 and 2008 you were Director of AMIIF, before that you were Director of ANAFAM, and now we’re delighted to be…
See our Cookie Privacy Policy Here
